
TOKYO -- U.S.-based Arch Venture Partners has launched a $3 billion venture capital fund specializing in medical technologies, one of the world's largest of its kind, with Japanese startups among its potential targets.
Fund looks to help develop startups short on capital, co-founder says
TOKYO -- U.S.-based Arch Venture Partners has launched a $3 billion venture capital fund specializing in medical technologies, one of the world's largest of its kind, with Japanese startups among its potential targets.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.